Rivaroxaban Impurity A CAS 931204-39-6: Structure, Analysis, and Pharmaceutical Quality Control

Detailed insights into a critical impurity in Rivaroxaban production, ensuring drug safety and efficacy.

Get a Quote & Sample

Advantages Offered

Enhanced Drug Purity

The rigorous characterization and quantification of this Rivaroxaban impurity help in achieving higher API purity, a cornerstone of pharmaceutical quality.

Regulatory Compliance

Adherence to ICH guidelines for drug impurity analysis is facilitated by the validated analytical methods for Rivaroxaban impurities.

Process Optimization

Understanding the formation pathways of this Rivaroxaban impurity aids in optimizing synthesis processes to minimize its presence.

Key Applications

Pharmaceutical Research

Essential for R&D activities focused on understanding and controlling impurities in Rivaroxaban.

Quality Control

Used in QC labs for routine testing of Rivaroxaban API and finished products to ensure they meet stringent standards.

Drug Development

Crucial for Abbreviated New Drug Application (ANDA) and DMF filing, supporting the development of safe and effective Rivaroxaban formulations.

Analytical Standards

Serves as a critical reference standard for developing and validating analytical methods for Rivaroxaban impurity analysis.